Back to Agenda
Session 2: Safe & Sure - Clinical Evidence & Performance Evaluation
Session Chair(s)
Satheesan Balasubramanian
Director, Malabar Cancer Centre, Thalassery, Kerala, MALABAR CANCER CENTRE, India
Session Focus: What “good evidence” actually means—and how to generate it efficiently. Covers performance evaluation logic, clinical evidence expectations, endpoints, study design choices, and documentation that stands up to scrutiny—so you don’t over-invest where it doesn’t add value, or under-invest and get stuck.
Speaker(s)
Anju Gopan
Medical Director, Oncology, IQVIA, India
Changing Paradigms in Clinical Trials and Validation of MedTech
Atonu Dutta
Founder and CEO, Neujin Solutions, India
Clinical Evaluation and Validation of MedTech Devices – Strengths and Challenges in India
Vivek Ahuja, MD
Program Chair, Executive Vice President, Pharmacovigilance, EVERSANA, India
Panel Discussion: Building Trust in MedTech – Ensuring Safety, Clinical Evidence, and Performance in India
E Sreekumar
Director, Institute of Advance Virology, India
Vijayakumar Manavalan
Pro Chancellor, Former Director , Yenapoya University, KIDWAI Memorial Institute of Oncology, India
Deepa Arora, MD
Director, Clinexel Life Sciences Private Limited, India
Have an account?